282,95 €
282,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
141 °P sammeln
282,95 €
282,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
141 °P sammeln
Als Download kaufen
282,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
141 °P sammeln
Jetzt verschenken
282,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
141 °P sammeln
  • Format: PDF

These volumes represent a comprehensive guide to prodrugs. They guide the reader through the current status of the prodrug concept and its many applications and highlight its many successes in overcoming formulation and delivery of problematic drugs. Replete with examples of approved and marketed prodrugs, these volumes introduce the topic to the novice as well as professional in the design of prodrugs.

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 30.81MB
Produktbeschreibung
These volumes represent a comprehensive guide to prodrugs. They guide the reader through the current status of the prodrug concept and its many applications and highlight its many successes in overcoming formulation and delivery of problematic drugs. Replete with examples of approved and marketed prodrugs, these volumes introduce the topic to the novice as well as professional in the design of prodrugs.


Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Valentino Stella, University of Kansas, Lawrence, KS, USA / Ronald Borchardt, University of Kansas, Lawrence, KS, USA / Michael Hageman, Bristol-Myers Squibb Company, Princeton, NJ, USA / Reza Oliyai, Gilead Sciences, Foster City, CA, USA / Hans Maag, Roche Palo Alto, LLC, Palo Alto, CA, USA / Jefferson Tilley, Hoffmann-La Roche Inc., Nutley, NJ, USA
Rezensionen
From the reviews:

"The editors provide a comprehensive overview on early and current prodrug strategies. ... medicinal chemists will highly appreciate this book. ... the book should be available in the libraries of every pharmaceutical and small-molecule biotech company." -- Hugo Kubinyi, ChemMedChem, Issue 3, 2008